Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Levothyroxine sodium
Medication labelHypothyroidism Levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and…
Why this: Advisory · dailymed-prescription
Hypothyroidism Levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use: Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see Warnings and Precautions (5.4)]. Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
- generic_name
- levothyroxine sodium
- product_names
- levothyroxine sodium
- ndc
- 72865-236, 72865-237, 72865-238, 72865-239, 72865-240, 72865-241, 72865-242, 72865-243, 72865-244, 72865-245, 72865-246, 72865-247, 72865-236-90, 72865-236-10, 72865-237-90, 72865-237-10, 72865-238-90, 72865-238-10, 72865-239-90, 72865-239-10, 72865-240-90, 72865-240-10, 72865-241-90, 72865-241-10, 72865-242-90, 72865-242-10, 72865-243-90, 72865-243-10, 72865-244-90, 72865-244-10, 72865-245-90, 72865-245-10, 72865-246-90, 72865-246-10, 72865-247-90, 72865-247-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en